| Djordje Boskov, MD | |
|
566 S Hillcrest Ave, Elmhurst, IL 60126-4146 | |
| (952) 595-1100 | |
| (612) 294-4903 |
| Full Name | Djordje Boskov |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 25 Years |
| Location | 566 S Hillcrest Ave, Elmhurst, Illinois |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578564696 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD476695 (Pennsylvania) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 036109171 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Imaging Sc | 3678892247 | 19 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its next generation DNA sequencing and data analysis services, to enable researchers to better explore the genomic origins of disease.
Scientists say they believe as many as 53 million people may carry the superbug MRSA.
The Lancet, the world's leading independent general medical journal, today announced its first app for iPad is now available on the App Store. The Lancet App is an innovative article-based navigation app that makes it easier for healthcare professionals (HCPs) to find the information they need quickly and efficiently from the convenience of their iPad.
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.
Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.
› Verified 9 days ago
| Entity Name | Cal Devon Urgent Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104940618 PECOS PAC ID: 6507939204 Enrollment ID: O20080818000783 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its next generation DNA sequencing and data analysis services, to enable researchers to better explore the genomic origins of disease.
Scientists say they believe as many as 53 million people may carry the superbug MRSA.
The Lancet, the world's leading independent general medical journal, today announced its first app for iPad is now available on the App Store. The Lancet App is an innovative article-based navigation app that makes it easier for healthcare professionals (HCPs) to find the information they need quickly and efficiently from the convenience of their iPad.
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.
Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.
› Verified 9 days ago
| Entity Name | Spectrum Imaging Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821482621 PECOS PAC ID: 3678892247 Enrollment ID: O20150501002011 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its next generation DNA sequencing and data analysis services, to enable researchers to better explore the genomic origins of disease.
Scientists say they believe as many as 53 million people may carry the superbug MRSA.
The Lancet, the world's leading independent general medical journal, today announced its first app for iPad is now available on the App Store. The Lancet App is an innovative article-based navigation app that makes it easier for healthcare professionals (HCPs) to find the information they need quickly and efficiently from the convenience of their iPad.
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.
Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Djordje Boskov, MD 11995 Singletree Ln, Ste 500, Eden Prairie, MN 55344-5347 Ph: (952) 595-1301 | Djordje Boskov, MD 566 S Hillcrest Ave, Elmhurst, IL 60126-4146 Ph: (952) 595-1100 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its next generation DNA sequencing and data analysis services, to enable researchers to better explore the genomic origins of disease.
Scientists say they believe as many as 53 million people may carry the superbug MRSA.
The Lancet, the world's leading independent general medical journal, today announced its first app for iPad is now available on the App Store. The Lancet App is an innovative article-based navigation app that makes it easier for healthcare professionals (HCPs) to find the information they need quickly and efficiently from the convenience of their iPad.
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.
Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.
› Verified 9 days ago
Regina Liebman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 N Berteau Ave, Elmhurst, IL 60126 Phone: 630-833-1400 | |
Jerold Bart Weinberg, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 200 N Berteau Ave, Elmhurst, IL 60126 Phone: 630-833-1400 | |
Barry D Lessin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 N Berteau Ave, Elmhurst, IL 60126 Phone: 630-833-1400 | |
Lee N Dennis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 N Berteau Ave, Elmhurst, IL 60126 Phone: 630-833-1400 | |
David Wasserman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 N Berteau Ave, Elmhurst, IL 60126 Phone: 630-833-1400 | |
Dr. Nishant Kumar, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 155 E. Brush Hill Road, Elmhurst, IL 60126 Phone: 331-221-5420 |